Lung Cancer Screening Market Forecast 2026–2035: Data Trends and Industry Insights
Uncover key drivers, emerging technologies, and competitive movements shaping the lung cancer screening market from 2026–2035 with trusted insights from The Business Research Company
What is the estimated market size of the Lung Cancer Screening Market by the end of 2030?
The lung cancer screening market has demonstrated significant growth in recent years. It is projected to increase from $3.33 billion in 2025 to $3.65 billion in 2026, with a compound annual growth rate (CAGR) of 9.6%. The expansion observed in the past can be ascribed to a rising prevalence of lung cancer among older populations, enhanced recognition of the benefits of early screening, the development of diagnostic imaging infrastructure, advancements in CT imaging technology, and the adoption of screening protocols based on guidelines.
The lung cancer screening market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach $5.24 billion, achieving a compound annual growth rate (CAGR) of 9.5%. Factors contributing to this growth during the forecast period include the greater uptake of AI-assisted diagnostic processes, the spread of population-level screening initiatives, a heightened emphasis on personalized risk evaluation, increasing investments in technologies for early cancer detection, and enhanced healthcare policy backing for screening. Key trends during the projected period encompass the wider implementation of low-dose CT screening programs, the growing incorporation of AI into imaging analysis, a stronger focus on screening high-risk populations, the broadening of preventive oncology efforts, and an intensified priority on detecting lung cancer at earlier stages.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27331&type=smp
What Drivers Are Shaping Future Opportunities In The Lung Cancer Screening Market?
Elevated smoking rates are projected to significantly boost the expansion of the lung cancer screening market. Smoking involves inhaling smoke, typically from burning tobacco, into the mouth and lungs. The increase in smoking prevalence stems from heightened stress levels, causing more individuals to adopt smoking as a coping strategy. Lung cancer screening plays a crucial role in tackling these increasing smoking rates by facilitating the prompt identification of health hazards linked to smoking, thereby encouraging individuals to cease the habit and contributing to wider public health initiatives aimed at diminishing tobacco consumption. For example, the Office for Health Improvement & Disparities, a UK-based government organisation, reported in October 2024 that the percentage of current smokers within the routine and manual occupation group (aged 18 to 64) in 2023 stood at 19.5%. Consequently, the growing incidence of smoking is propelling the development of the lung cancer screening market.
Which Segment Groups Are Influencing The Lung Cancer Screening Market?
The lung cancer screening market covered in this report is segmented –
1) By Diagnosis Type: Low Dose Spiral Computed Tomography Scan, Chest-X-Ray
2) By Cancer Type: Non-Small Cell Lung Cancer, Small Cell Lung Cancer
3) By Age Group: 50 And Older, Below 50
4) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users
Subsegments:
1) By Low Dose Spiral Computed Tomography Scan: Screening, Diagnostic, Follow-Up
2) By Chest X-Ray: Posterior Anterior, Lateral, Portable
What Upcoming Trends Are Likely To Define The Future Path Of The Lung Cancer Screening Market?
Major companies operating in the lung cancer screening market are prioritizing the development of advanced solutions, such as normal flagging, to improve diagnostic accuracy, lessen false positives, and enhance the early detection of cancerous nodules. Normal flagging is a technological attribute in lung cancer screening that automatically recognizes and marks scans without abnormal findings, thus helping to prioritize cases needing more detailed review. For instance, in May 2025, Lunit Inc., a medical technology company from South Korea, unveiled INSIGHT CXR4, its next-generation artificial intelligence (AI)-powered chest X-ray analysis solution, which has achieved CE MDR-certification for implementation across Europe. This solution, designed to support radiologists with enhanced diagnostic accuracy and workflow efficiency, identifies 12 chest abnormalities, including lung nodules, pneumonia, and acute bone fractures, and integrates features like current-prior image comparison to assist in early disease detection and clinical decision-making.
Who Are The Core Companies Influencing Trends In The Lung Cancer Screening Market?
Major companies operating in the lung cancer screening market are Abbott Laboratories Inc., Canon Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Quest Diagnostics Incorporated, Shimadzu Corporation, NeoGenomics Laboratories Inc., Freenome Holdings Inc., Biodesix Inc., Lunit Inc., Infervision, Riverain Technologies, VisionGate, Delfi Diagnostics Inc., Hologic Inc., Fujifilm Holdings Corporation, United Imaging Healthcare Co. Ltd., Samsung Medison Co. Ltd., Carestream Health Inc., Analogic Corporation, Toshiba Medical Systems Corporation
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/lung-cancer-screening-global-market-report
Which Region Is Expected To Experience The Fastest Growth In The Lung Cancer Screening Market?
North America was the largest region in the lung cancer screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Lung Cancer Screening Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27331&type=smp
Browse Through More Reports Similar to the Global Lung Cancer Screening Market 2026, By The Business Research Company
Ecommerce Fraud Detection And Prevention Market Report 2026
Financial Fraud Detection Software Market Report 2026
Payment Monitoring Market Report 2026
https://www.thebusinessresearchcompany.com/report/payment-monitoring-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
